{
    "code": "56030083",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=56030083",
    "time": "2019-02-15 04:02:40",
    "許可證字號": "衛部醫器輸字第030083號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "111\/10\/26",
    "發證日期": "106\/10\/26",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第三等級",
    "通關簽審文件編號": "DHA05603008301",
    "中文品名": "0.8%艾芬瑪金紅血球試劑(混合細胞)",
    "英文品名": "0.8% Affirmagen",
    "效能": "確認血液中ABO血型抗體(A1及B)的一種定性試驗。需搭配拜而優系統(BioVue System)使用。",
    "醫器規格": "719202，以下空白。\r\n規格（新增適用機型）、標籤及仿單變更為：詳如中文仿單核定本（原106年11月27日仿單標籤核定本正本收回作廢）。",
    "劑型": "",
    "包裝": "",
    "標籤、仿單及包裝加註": "",
    "": "",
    "醫器主類別一": "B血液學及病理學裝置",
    "醫器次類別一": "B9175自動血液分類及抗體試驗系統",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "主成分略述": [
        ""
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "620118D857  台灣大昌華嘉股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F460139200  ORTHO-CLINICAL DIAGNOSTICS, INC.",
        "製造廠廠址": "1001 U.S. HIGHWAY 202, RARITAN, NEW JERSEY 08869 U.S.A.",
        "製造廠公司地址": "",
        "": ""
    },
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "56030083-108-02-11.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56030083&Seq=002&Type=9"
        },
        {
            "title": "56030083-108-02-11.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56030083&Seq=002&Type=8"
        }
    ]
}